title: Regulatory considerations for clinical mass spectrometry: multiple reaction monitoring.
authors: Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors: Emily S
authors: ES
authors: Boja
authors: Henry
authors: H
authors: Rodriguez
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood / Q000592:standards*; D019963:Clinical Chemistry Tests / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods* / Q000592:standards*; D017410:Practice Guidelines as Topic; D040901:Proteomics / Q000379:methods* / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards
chemical_list: D014408:Biomarkers, Tumor